< Back to search
Filter
1

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

for
T Cell Non-Hodgkin Lymphoma
Location: New York NY, Philadelphia PA
Sponsor: Vittoria Biotherapeutics

Sex: All

Age: 18+

Code: NCT06420089

Phase1, Recruiting

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

for
B-cell Acute Lymphoblastic Leukemia,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 30

Code: NCT04544592

Phase1, Phase2, Recruiting

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

for
B-cell Malignancy, Relapsed Cancer, Refractory Cancer,
Location: New York NY, Philadelphia PA, Rochester NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06634589

Phase1, Phase2, Recruiting

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT06249191

Phase1, Phase2, Recruiting

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

for
Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma,
Location: San Francisco CA
Sponsor: C. Babis Andreadis

Sex: All

Age: 18+

Code: NCT04545762

Phase1, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Fairfax VA, Pittsburgh PA, Canton OH, Columbus OH,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase1, Recruiting

Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma

for
Sarcoidosis, Lymphoma, Adenopathy Hilar
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT03573362

Recruiting

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

for
Prostate Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3+

Code: NCT01441089

Recruiting

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

for
Multiple Myeloma, Lymphoma, Non-Hodgkin,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT02682667

Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

for
T-cell Lymphoma, T-cell Leukemia
Location: New York NY, Miami FL, Indianapolis IN, Houston TX
Sponsor: Huda Salman

Sex: All

Age: 12+

Code: NCT03829540

Phase1, Recruiting

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

for
B-Cell Non-Hodgkin Lymphoma,
Location: Westwood KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT06879340

Phase1, Recruiting

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

for
Recurrent Grade 1 Follicular Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06453044

Phase2, Recruiting

BHB & CAR-T for Lymphomas

for
Large B-cell Lymphoma
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06610344

Recruiting

A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

for
Lymphomas, B-cell Lymphomas
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05773040

Phase1, Recruiting

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

for
Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma,
Location: Boston MA, New York NY, Philadelphia PA, Miami FL,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT06137144

Phase1, Phase2, Recruiting

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

for
Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06377540

Phase2, Recruiting

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

for
Cutaneous T-cell Lymphoma
Location: Commack NY, Rockville Centre NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05296304

Phase1, Recruiting

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

for
Hematologic Malignancy, Large B-cell Lymphoma,
Location: Los Angeles CA
Sponsor: Joshua Sasine, MD, PhD

Sex: All

Age: 18 - 70+

Code: NCT05887167

Phase1, Recruiting

Pembro Plus CAR T-cell Therapy in R/R in PMBCL

for
Primary Mediastinal Large B-cell Lymphoma (PMBCL),
Location: Boston MA, New York NY
Sponsor: Jennifer Crombie, MD

Sex: All

Age: 18+

Code: NCT05934448

Phase2, Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase3, Recruiting